SCIENCE HAMMERS YET ANOTHER NAIL IN THE COFFIN OF THE GOVERNMENT’S CREDIBILITY
by Kieron McFadden
With its entire narrative alleging the existence of a mass-killing pandemic thoroughly discredited – by the government’s own stats no less! – and the relentless procession of outright lies that created the narrative exposed, yet another nail in the coffin of the government’s credibility has been hammered home by the publication of a bombshell scientific paper entitled, “Why are we vaccinating children against COVID-19?”.
Covid Critics Vindicated
The paper further vindicates most thoroughly the thousands of medical professionals, observers and people’s media outlets that have campaigned tirelessly to alert the public to the hostile agenda behind the government’s fabricated “health crisis” and what is now widely understood to be its booby-trapped pseudo-vaccine “solution”.
These revelations have placed the engineers of and collaborators with the Covid operation in severe danger from the inevitable public wrath as the extent of its dishonesty and the mounting casualties that have resulted permeate the government/MSM cover-up.
Calls for Criminal Investigation hard to deny
Many are calling now for a full criminal investigation to unmask and punish the culprits and it is hard to see now how this call can be ignored.
We should also add that until justice is brought to bear and steps are taken to eliminate such deadly criminality on the part of politicians, ministers, bureaucrats and those driving the agenda of the pharmaceutical corporations, the capacity for wide-spread harm by an insane few will remain a blight upon and threat to the lives, peace of mind and well being of every citizen and their children.
In the meantime, the bombshell paper:
Explains why the C_V_D-19 injections are in fact a “treatment” deceptively mis-labelled a vaccine.
Shows why the clinical trials predicted neither (a) the seriousness of the immediate- and short-term adverse events that have occurred nor (b) the potential extent of the underlying pre-symptomatic damage (ie, damage that has not yet manifested symptoms but is likely to do so as time goes on) that has occurred as a result of the injections.
Summarizes the adverse events that have occurred as of mid-June (as reported in VAERS) from the mass injections.
Presents biological evidence to support the potential occurrence of many more adverse effects from these injections in the mid- and long-term.
Examines why the normalized post-injection deaths are “few”, but (contrary to government claims) not negligible, in children.
Provides a detailed analysis of the major clinical trials that were used to justify Emergency Use Authorization (EUA) for the “inoculants” presently being administered in the USA and elsewhere.
Presents a novel best-case scenario cost-benefit analysis of the C_V_D-19 inoculations that have been administered in the USA.
Please check out the paper for yourself and you’ll find the science establishes:
People in the 65+ demographic are five times as likely to die from the pseudo-vax injection (we cannot accurately call it vaccination or inoculation) as from COVID-19 under the most favorable assumptions!
The long-term cost-benefit ratio under the best-case scenario could well be on the order of 10/1, 20/1, or more for all the demographics, increasing with decreasing age.
And here are further conclusions quoted directly from the paper itself
Bulk of COVID-19 per capita deaths occur in elderly with high comorbidities.
Per capita COVID-19 deaths are negligible in children.
Clinical trials for these inoculations were very short-term.
Clinical trials did not address long-term effects most relevant to children.
High post-inoculation deaths reported in VAERS (very short-term).
This article examines issues related to COVID-19 inoculations for children. The bulk of the official COVID-19-attributed deaths per capita occur in the elderly with high comorbidities, and the COVID-19 attributed deaths per capita are negligible in children. The bulk of the normalized post-inoculation deaths also occur in the elderly with high comorbidities, while the normalized post-inoculation deaths are small, but not negligible, in children. Clinical trials for these inoculations were very short-term (a few months), had samples not representative of the total population, and for adolescents/children, had poor predictive power because of their small size. Further, the clinical trials did not address changes in biomarkers that could serve as early warning indicators of elevated predisposition to serious diseases. Most importantly, the clinical trials did not address long-term effects that, if serious, would be borne by children/adolescents for potentially decades.
A novel best-case scenario cost-benefit analysis showed very conservatively that there are five times the number of deaths attributable to each inoculation vs those attributable to COVID-19 in the most vulnerable 65+ demographic. The risk of death from COVID-19 decreases drastically as age decreases, and the longer-term effects of the inoculations on lower age groups will increase their risk-benefit ratio, perhaps substantially.